PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.79%
Positive revenue growth while OGI.TO is negative. John Neff might see a notable competitive edge here.
-55.89%
Negative gross profit growth while OGI.TO is at 165.96%. Joel Greenblatt would examine cost competitiveness or demand decline.
-110.68%
Negative EBIT growth while OGI.TO is at 348.41%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-110.68%
Negative operating income growth while OGI.TO is at 348.41%. Joel Greenblatt would press for urgent turnaround measures.
-140.68%
Negative net income growth while OGI.TO stands at 538.90%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-129.18%
Negative EPS growth while OGI.TO is at 52.17%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-128.65%
Negative diluted EPS growth while OGI.TO is at 50.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
40.06%
Share reduction more than 1.5x OGI.TO's 310.35%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
37.54%
Diluted share reduction more than 1.5x OGI.TO's 340.82%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-4001.79%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
29.11%
Positive FCF growth while OGI.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
428.38%
3Y revenue/share CAGR above 1.5x OGI.TO's 43.20%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-2160.23%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-519.63%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-44.26%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-325.17%
Negative 10Y net income/share CAGR while OGI.TO is at 2384.37%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1884.91%
Negative 5Y net income/share CAGR while OGI.TO is 2406.25%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-128.25%
Negative 3Y CAGR while OGI.TO is 13057.43%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
4744.30%
Equity/share CAGR of 4744.30% while OGI.TO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
5474.80%
5Y equity/share CAGR above 1.5x OGI.TO's 1092.41%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
1855.02%
3Y equity/share CAGR above 1.5x OGI.TO's 877.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-85.62%
Firm’s AR is declining while OGI.TO shows 4.15%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
86.58%
Inventory growth well above OGI.TO's 141.09%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
52.33%
Asset growth above 1.5x OGI.TO's 11.19%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
11.30%
Positive BV/share change while OGI.TO is negative. John Neff sees a clear edge over a competitor losing equity.
-20.34%
We’re deleveraging while OGI.TO stands at 0.48%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
86.76%
R&D growth of 86.76% while OGI.TO is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
55.94%
We expand SG&A while OGI.TO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.